13F-HR filed by FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 89 holding rows worth $21,675,731,270.
- Accession
- 0000908834-26-000432
- Filer
- CIK 909661
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 89 entries on the cover page, a total value of $21,675,731,270 stated on the cover page (in dollars after the unit check, H1), rows summing to $21,675,731,270 with VALUE read as dollars as filed, 13F file number 028-03896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 6,000,000 | $4,480,620,000 | dollars as filed | put |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 13,550,796 | $2,537,793,075 | dollars as filed | |
| ELECTRONIC ARTS INC COM | 285512109 | Stock | 7,919,500 | $1,623,814,280 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 10,743,063 | $800,143,332 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 6,348,906 | $778,248,897 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 13,468,010 | $732,794,424 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 8,365,038 | $666,944,480 | dollars as filed | |
| Amazon.com, Inc | 023135106 | COM | 2,632,994 | $627,547,790 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 5,583,479 | $619,431,160 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,218,366 | $602,175,451 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 1,270,532 | $528,071,215 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 1,049,185 | $526,019,392 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 14,309,000 | $506,395,510 | dollars as filed | |
| AON PLC SHS CL A | G0403H108 | Stock | 1,382,562 | $458,581,990 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 10,521,184 | $449,044,133 | dollars as filed | |
| Broadcom Inc. | 11135F101 | COM | 1,151,800 | $435,092,450 | dollars as filed | |
| Microsoft Corp | 594918104 | COM | 1,112,863 | $415,120,156 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 12,277,000 | $383,779,020 | dollars as filed | |
| KKR & CO INC | 48251W104 | COM | 4,118,300 | $377,977,574 | dollars as filed | |
| SYNOPSYS INC COM | 871607107 | Stock | 829,600 | $370,059,672 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 10,236,396 | $351,313,111 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 8,989,098 | $336,372,047 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 4,161,584 | $284,111,340 | dollars as filed | |
| WABTEC COM | 929740108 | Stock | 894,503 | $241,158,009 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 5,805,000 | $223,666,650 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 2,136,400 | $219,792,832 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 5,917,400 | $219,594,714 | dollars as filed | |
| ARAMARK COM | 03852U106 | Stock | 3,625,731 | $206,304,094 | dollars as filed | |
| BAIDU INC SPON ADR REP A | 056752108 | ADR | 1,203,785 | $137,580,588 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 2,619,000 | $125,554,860 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 4,220,800 | $124,640,224 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 1,732,800 | $120,845,472 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 574,000 | $108,841,880 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 408,000 | $103,619,760 | dollars as filed | |
| ISHARES TR | 464287523 | COM | 130,000 | $83,298,800 | dollars as filed | put |
| STRATEGY INC | 594972AS0 | NOTE12/0 | 87,858,000 | $75,366,666 | dollars as filed | principal |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 2,368,200 | $64,817,634 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 363,000 | $56,889,360 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 322,200 | $48,339,666 | dollars as filed | |
| VNET GROUP INC | 90138AAE3 | NOTE 2.000%10/0 | 45,000,000 | $46,808,834 | dollars as filed | principal |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 2,498,000 | $46,163,040 | dollars as filed | |
| JOYY INC ADS REPSTG COM A | 46591M109 | ADR | 699,200 | $46,140,208 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 1,604,590 | $44,094,133 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 2,418,202 | $35,257,385 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,107,814 | $33,057,170 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 400,000 | $28,420,000 | dollars as filed | call |
| Merck & Co.,Inc. | 58933Y105 | COM | 199,000 | $25,571,500 | dollars as filed | |
| WARBY PARKER INC | 93403J106 | CL A COM | 828,000 | $25,121,520 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 2,250,000 | $24,480,000 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 1,100,000 | $24,233,000 | dollars as filed | |
| RIO TINTO PLC SPONSORED ADR | 767204100 | ADR | 183,475 | $17,417,282 | dollars as filed | |
| AXALTA COATING SYS LTD COM | G0750C108 | Stock | 478,000 | $16,357,160 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 122,000 | $16,257,720 | dollars as filed | |
| VNET GROUP INC | 90138A103 | SPONSORED ADS A | 1,992,000 | $16,015,680 | dollars as filed | |
| NETEASE COM INC SPONSORED ADS | 64110W102 | ADR | 123,500 | $15,825,290 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 71,000 | $15,340,260 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,250,000 | $15,322,500 | dollars as filed | |
| MOBIA MED INC | 60705V103 | COMMON STOCK | 1,128,557 | $15,122,664 | dollars as filed | |
| STRATEGY INC | 594972AN1 | NOTE 2.250% 6/1 | 15,000,000 | $14,189,967 | dollars as filed | principal |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 2,365,000 | $13,125,750 | dollars as filed | |
| ALAMAR BIOSCIENCES INC | 010911105 | COMMON STOCK | 462,900 | $12,539,961 | dollars as filed | |
| ALVOTECH | L01800108 | ORDINARY SHARES | 2,859,675 | $10,552,201 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 595,000 | $9,323,650 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 3,325,000 | $7,448,000 | dollars as filed | |
| SCOTTS MIRACLE-GRO CO | 810186106 | CL A | 88,000 | $5,993,680 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 264,900 | $5,438,397 | dollars as filed | |
| BRUNSWICK CORP | 117043109 | COM | 61,000 | $5,138,640 | dollars as filed | |
| GENTEX CORP COM | 371901109 | Stock | 199,000 | $5,028,730 | dollars as filed | |
| IDEXX LABS INC COM | 45168D104 | Stock | 9,000 | $4,737,960 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,240,843 | $4,578,711 | dollars as filed | |
| COMMERCIAL METALS CO COM | 201723103 | Stock | 67,000 | $4,204,250 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 300,000 | $3,408,000 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 415,000 | $3,207,950 | dollars as filed | |
| STRATEGY INC | 594972AU5 | NOTE 3/0 | 2,632,000 | $2,318,158 | dollars as filed | principal |
| SUMMIT MIDSTREAM CORP | 86614G101 | COMMON STOCK | 58,214 | $1,657,935 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 40,000 | $1,355,200 | dollars as filed | |
| REVOLUTION MEDICINES INC | 76155X118 | *W EXP 12/17/202 | 120,085 | $1,128,799 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 17,000 | $657,900 | dollars as filed | |
| ALEANNA INC | 01444V111 | *W EXP 12/13/202 | 990,000 | $297,000 | dollars as filed | |
| ALEANNA INC | 01444V103 | COM CL A | 78,400 | $227,360 | dollars as filed | |
| WELLTOWER INC COM | 95040Q104 | REIT | 1,000 | $226,970 | dollars as filed | |
| Solid Power Inc W Exp 12/08/202 | 83422N113 | SPAC Combination | 405,316 | $41,423 | dollars as filed | |
| BLUE GOLD LTD | G1331C112 | *W EXP 04/01/203 | 255,800 | $30,696 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 14,200 | $23,856 | dollars as filed | |
| GERON CORP | 374163103 | COM | 14,400 | $18,432 | dollars as filed | |
| Nvni Group Limited W Exp 11/01/202 | G50716110 | SPAC Combination | 375,000 | $17,550 | dollars as filed | |
| CANOPY GROWTH CORPORATION COM NEW | 138035704 | Stock | 18,000 | $17,100 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 20,700 | $15,740 | dollars as filed | |
| BEYOND MEAT INC | 08862E109 | COM | 19,000 | $14,250 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000908834-26-000432 | this filing | 2026-08-14 | acceptance time not in the bulk data set |